nifedipine has been researched along with bendroflumethiazide in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (47.62) | 18.7374 |
| 1990's | 6 (28.57) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Adnitt, P; Battersby, C; Bulpitt, CJ; Fletcher, AE; Jurgensen, HJ; Underwood, N | 1 |
| Buckley, MG; Cappuccio, FP; MacGregor, GA; Markandu, ND; Miller, MA; Sagnella, GA; Singer, DR | 1 |
| Cappuccio, FP; MacGregor, GA; Markandu, ND | 1 |
| MacGregor, GA; Markandu, ND; Singer, DR | 1 |
| Schoenberger, JA | 1 |
| Beevers, DG; Gill, JS; Zezulka, AV | 1 |
| Cappuccio, FP; MacGregor, GA; Markandu, ND; Shore, AC; Tucker, FA | 1 |
| Cappuccio, FP; MacGregor, GA; Markandu, ND; Pevahouse, JB | 1 |
| Parnell, L; Ramsay, LE; Waller, PC | 1 |
| Cappuccio, FP; MacGregor, GA; Markandu, ND; Sagnella, GA; Tucker, F | 1 |
| Barbour, MP; Forret, EA; Hill, TW; Lawrie, TD; Lorimer, AR; McAlpine, HM; Rae, AP; Simpson, IA | 1 |
| Conway, J | 1 |
| Hommel, E; Parving, HH; Rossing, P; Smidt, UM | 1 |
| Belgrave, GP; Hosie, J; Nasar, MA; Walters, EG | 1 |
| Bevan, EG; Carmichael, HA; Findlay, JG; Herrick, AL; Lorimer, AR; Murray, GD; Pringle, SD; Reid, JL; Waller, PC; Weir, RJ | 1 |
| Isles, CG; Kitchin, NR | 1 |
| Girvin, BG; Johnston, GD | 1 |
| Chapman, N; Gabriel, C; Nandoskar, A; Tomek, M | 1 |
2 review(s) available for nifedipine and bendroflumethiazide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Calcium antagonists: use in hypertension evaluation of calcium antagonists in combination with diuretics.
Topics: Bendroflumethiazide; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Nifedipine; Nitrendipine | 1988 |
14 trial(s) available for nifedipine and bendroflumethiazide
| Article | Year |
|---|---|
Quality of life on antihypertensive therapy: a double-blind trial comparing quality of life on pinacidil and nifedipine in combination with a thiazide diuretic. European Pinacidil Study Group.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Data Interpretation, Statistical; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Guanidines; Humans; Hypertension; Male; Middle Aged; Nifedipine; Pinacidil; Quality of Life; Sodium Chloride Symporter Inhibitors | 1992 |
A double-blind crossover study of the effect of concomitant diuretic therapy in hypertensive patients treated with amlodipine.
Topics: Adult; Amlodipine; Bendroflumethiazide; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Hypokalemia; Male; Middle Aged; Nifedipine; Potassium | 1991 |
Calcium antagonists and sodium balance: effect of changes in sodium intake and of the addition of a thiazide diuretic on the blood pressure lowering effect of nifedipine.
Topics: Adult; Bendroflumethiazide; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Sodium, Dietary | 1987 |
Calcium antagonists: use in hypertension evaluation of calcium antagonists in combination with diuretics.
Topics: Bendroflumethiazide; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Nifedipine; Nitrendipine | 1988 |
The effects of bendroflumethiazide added to nifedipine in patients with hypertension.
Topics: Adult; Bendroflumethiazide; Blood Glucose; Blood Pressure; Body Weight; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Humans; Hypertension; Middle Aged; Nifedipine; Potassium; Pulse; Random Allocation; Uric Acid | 1987 |
A double-blind study of the blood pressure lowering effect of a thiazide diuretic in hypertensive patients already on nifedipine and a beta-blocker.
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Random Allocation | 1987 |
Comparison of nifedipine, prazosin and hydralazine added to treatment of hypertensive patients uncontrolled by thiazide diuretic plus beta-blocker.
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Blood Pressure; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Male; Middle Aged; Nifedipine; Prazosin; Random Allocation | 1987 |
Effects of felodipine on rest and exercise heart rate and blood pressure in hypertensive patients.
Topics: Adult; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Felodipine; Female; Heart Rate; Humans; Hypertension; Male; Metoprolol; Middle Aged; Nifedipine; Physical Exertion; Random Allocation | 1985 |
Third-line therapy. A cautionary note.
Topics: Atenolol; Bendroflumethiazide; Captopril; Chlorthalidone; Female; Humans; Hypertension; Male; Methyldopa; Nifedipine | 1985 |
Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Bendroflumethiazide; Blood Pressure; Captopril; Cholesterol; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Female; Furosemide; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Hypertension; Kidney; Least-Squares Analysis; Male; Middle Aged; Nifedipine; Prognosis; Prospective Studies; Regression Analysis | 1995 |
A comparative study of long acting diltiazem (Tildiem LA) with sustained release nifedipine (nifedipine SR) and bendrofluazide in the treatment of mild to moderate hypertension.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Delayed-Action Preparations; Diltiazem; Drug Therapy, Combination; Electrolytes; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Patient Dropouts | 1994 |
Effects of atenolol withdrawal in patients on triple antihypertensive therapy.
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Captopril; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Renin; Treatment Outcome | 1993 |
A randomised double-blind study comparing nifedipine GITS 20 mg and bendrofluazide 2.5 mg administered once daily in mild-to-moderate hypertension.
Topics: Aged; Bendroflumethiazide; Blood Pressure; Calcium Channel Blockers; Diuretics; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Sodium Chloride Symporter Inhibitors; Treatment Outcome | 1999 |
Comparison of the effects of a 7-day period of non-compliance on blood pressure control using three different antihypertensive agents.
Topics: Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Calcium Channel Blockers; Enalapril; Humans; Hypertension; Nifedipine; Self Administration; Treatment Refusal | 2004 |
6 other study(ies) available for nifedipine and bendroflumethiazide
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Diuretics and calcium antagonists in hypertension.
Topics: Bendroflumethiazide; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Nifedipine; Sodium Chloride Symporter Inhibitors; Verapamil | 1988 |
Nifedipine, sodium intake, diuretics, and sodium balance.
Topics: Bendroflumethiazide; Blood Pressure; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Natriuresis; Nifedipine; Sodium, Dietary | 1987 |
Does a diuretic cause a further fall in blood pressure in hypertensive patients already on nifedipine?
Topics: Adult; Aged; Bendroflumethiazide; Blood Pressure; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Time Factors | 1986 |
Facial nerve palsy in the setting of malignant hypertension: a link not to be missed.
Topics: Adult; Antihypertensive Agents; Bell Palsy; Bendroflumethiazide; Bisoprolol; Facial Nerve; Facial Paralysis; Humans; Hypertension, Malignant; Magnetic Resonance Imaging; Male; Nifedipine | 2015 |